Skip to main content

CSS LLC/IL

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1103646 CHICAGO, IL

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,722,568
+$1,722,568 QoQ
Shares Held
42,818
Ownership
0.033%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Mar 31, 2026
CallValue
$1,581,039
CallShares
39,300
PutValue
$1,810,350
PutShares
45,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CSS LLC/IL holds $14,889,923 across 15 Biotechnology names. APLS ranks #2 (11.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 APLS
Apellis Pharmaceuticals, Inc.
This page
42,818 $1,722,568

All Filings in APLS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,722,568 42,818
2026-03-31 $1,581,039 39,300
2026-03-31 $1,810,350 45,000
2022-09-30 $1,434,300 21,000
2022-09-30 $464,440 6,800
2022-03-31 $259,131 5,100
2022-03-31 $1,956,185 38,500
2022-03-31 $73,471 1,446
2020-03-31 $187,530 7,000
2020-03-31 $120,555 4,500